HOT: Hemiarthroplasty Or Total Elbow Arthroplasty in the Elderly.

Sponsor
Royal Devon and Exeter NHS Foundation Trust (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04646798
Collaborator
(none)
20
2
2
36
10
0.3

Study Details

Study Description

Brief Summary

A feasibility study to assess the practicality, and obtain preliminary data to inform, a definitive Randomise Control Trial (RCT) in patients over the age of 65 diagnosed with un-reconstructible distal humeral fractures, to determine if there are differences in functional outcomes between those undergoing a hemiarthroplasty and a total elbow arthroplasty? Over an 18 month recruitment period the investigators will assess recruitment rates and participants willingness to be randomised to one of two routine clinical treatments. During a 1 year routine clinical follow up period (at 3 time points), routinely collected orthopaedic outcome data will be recorded and differences between groups explored.

Condition or Disease Intervention/Treatment Phase
  • Other: Hemiarthroplasty
  • Other: Total elbow arthroplasty
N/A

Detailed Description

Comminuted intra-articular distal humerus fractures (DHF) in the elderly population (over 65 years) have long been a treatment dilemma. Fixation of the fracture often results in development of arthritis and is associated with severe arthrofibrosis (stiffness) and pain. As a consequence, it has become standard practice that elderly patients with these injuries are treated with either elbow hemiarthroplasty (HA) or total elbow arthroplasty (TEA). Both allow immediate mobilisation of the affected arm, with good long term pain and range of motion outcomes reported for both implants in a variety of articles. However each implant has its own advantages and disadvantages.

Elbow HA allows full lifting and loading activities to continue in the operated elbow. However, the concern is that the metal articulation on native cartilage may result in wear and pain associated with this resulting in the need for conversion to a total elbow prosthesis. As this is revision surgery it carries additional risks over first time surgery. Secondly the collateral ligaments have to be reattached and this risks instability following the surgery if this fails.

Patients with TEA are required to avoid lifting and loading activities with the affected arm from the point of surgery and this is ongoing. Such activity can result in failure of the implant with bushing wear, or early progression to aseptic loosening. However, with complete resection of cartilage there is no concern of progressive ulna wear or pain and some literature has suggested a better range of motion due to the semi-constrained nature of the implant meaning condyle retention is not required.

To date no study has directly compared the two arthroplasty options for DHF's in elderly patients. Both implants are currently offered in the Royal Devon and Exeter, National Health Service Foundation Trust (RD&E NHS FT), while other trusts locally are known to offer only one approach. This reflect the uncertainty around which treatment may be better: current provision options are based on the operating surgeon's skills and clinical experience.

To address this state of clinical and personal equipoise will require a large, multi-centred, randomised controlled trial of HA vs TEA, for patients over the age of 65 diagnosed with un-reconstructible DHF's. Before this can be considered the investigators need to assess the feasibility of such a study, and obtain preliminary data to inform its development.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
20 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
To assess the feasibility of undertaking a randomised controlled trial of hemiarthroplasty versus total elbow arthroplasty for patients over the age of 65 who have an unreconstructible distal humeral fractureTo assess the feasibility of undertaking a randomised controlled trial of hemiarthroplasty versus total elbow arthroplasty for patients over the age of 65 who have an unreconstructible distal humeral fracture
Masking:
Single (Outcomes Assessor)
Masking Description:
Participant and clinician will not be masked. Data outcomes will be assessed by the research team utilising unique study Identifiers only and group allocation.
Primary Purpose:
Treatment
Official Title:
Hemiarthroplasty Or Total Elbow Arthroplasty for Unreconstructible Distal Humerus Fractures in the Elderly (HoT Elbow): a Feasibility Study
Anticipated Study Start Date :
Nov 30, 2020
Anticipated Primary Completion Date :
May 30, 2023
Anticipated Study Completion Date :
Nov 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Hemi Arthroplasty (HA) of the elbow.

Hemi Arthroplasty (HA) of the elbow, where the surgeon replaces the bottom of the humerus bone at the elbow.

Other: Hemiarthroplasty
standard surgical approaches to repair of fractured elbows

Active Comparator: Total Elbow Arthroplasty (TEA).

Total Elbow Arthroplasty (TEA), where the surgeon fits a new elbow joint replacing damaged parts of the humerus bone and forearm bone that it joins onto.

Other: Total elbow arthroplasty
standard surgical approaches to repair of fractured elbows

Outcome Measures

Primary Outcome Measures

  1. Recruitment rates [1-18 months]

    The number of patients willing to be recruited to the study will be presented as a percentage of the number who were approached, as having met the study inclusion criteria, and invited to join the study.

Secondary Outcome Measures

  1. randomisation/retention rates [1-30 months]

    The number of participants randomised to either of the treatment arms will be presented as a percentage of those recruited (randomisation rate). The number of participants completing all stages of the data collection phases will be presented as a percentage of the number of participants randomised and recruited (retention rate).

Other Outcome Measures

  1. Differences in clinical outcomes between groups as measured by the Oxford Elbow Score (OES) . [30-36 months]

    The OES is a short 12-item Patient Recorded Outcome measure specifically designed to assess outcomes of elbow surgery across 3 unidimensional domains: Elbow function, Pain and Social-psychological.

Eligibility Criteria

Criteria

Ages Eligible for Study:
65 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Aged 65 or over at time of surgery

  • Scheduled for operative repair by TEA or HA if fracture deemed unfixable.

  • Willing and able to provide informed consent

  • Willing and able to be randomly allocated to one of two surgical options

  • Willing and able to return for local routine clinical follow up

Exclusion Criteria:
  • Aged under 65 at time of surgery

  • Patients unable to independently consent for inclusion for any reason

  • Patients who have had previous elbow joint infections

  • Patients who will be unable or unlikely to be able to attend for local routine clinical follow-up (e.g. foreign nationals or holidaymakers who will seek follow-up away from our centre).

Contacts and Locations

Locations

Site City State Country Postal Code
1 NIHR Exeter Clinical Research Facility Exeter Devon United Kingdom EX2 5DW
2 Royal Devon and Exeter NHS Foundation Trust Exeter Devon United Kingdom EX2 5DW

Sponsors and Collaborators

  • Royal Devon and Exeter NHS Foundation Trust

Investigators

  • Study Director: Christopher Smith, MBBCH, Royal Devon and Exeter National Health Service Foundation trust

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Royal Devon and Exeter NHS Foundation Trust
ClinicalTrials.gov Identifier:
NCT04646798
Other Study ID Numbers:
  • R&D Study No: 2011059
First Posted:
Nov 30, 2020
Last Update Posted:
Nov 30, 2020
Last Verified:
Nov 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 30, 2020